What were Suraksha Diagnostic Ltd's latest quarterly results?
Suraksha Diagnostic Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +21.1%
- Revenue Growth YoY: +30.5%
- Operating Margin: 29.8%
Suraksha Diagnostic Ltd: Stock Analysis & Fundamentals
Updated this weekSuraksha Diagnostic Ltd (Diagnostics) — fundamental analysis, earnings data, and key metrics. PE: 36.8. ROE: 16.5%. This stock is not currently in the Nifty 500 momentum outperformers list.
What's Happening
📊Debt increased 33% YoY — leverage rising
🌐FII stake decreased 0.7% this quarter
Key Numbers
Current Price
₹236
Market Cap
1.2K Cr
Valuation
N/AFrequently Asked Questions: Suraksha Diagnostic Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Suraksha Diagnostic Ltd's current PE ratio?
Suraksha Diagnostic Ltd's current PE ratio is 36.8x.
- Current PE: 36.8x
- Market Cap: 1.2K Cr
What is Suraksha Diagnostic Ltd's price-to-book ratio?
Suraksha Diagnostic Ltd's price-to-book ratio is 5.3x.
- Price-to-Book (P/B): 5.3x
- Book Value per Share: ₹44
- Current Price: ₹236
Is Suraksha Diagnostic Ltd a fundamentally strong company?
Suraksha Diagnostic Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 18.0%
Is Suraksha Diagnostic Ltd debt free?
Suraksha Diagnostic Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹89 Cr
What is Suraksha Diagnostic Ltd's return on equity (ROE) and ROCE?
Suraksha Diagnostic Ltd's return ratios over recent years
- FY2023: ROCE 9.0%
- FY2024: ROCE 17.0%
- FY2025: ROCE 18.0%
Is Suraksha Diagnostic Ltd's cash flow positive?
Suraksha Diagnostic Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹63 Cr
- Free Cash Flow (FCF): ₹23 Cr
- CFO/PAT Ratio: 203% (strong cash conversion)
What is Suraksha Diagnostic Ltd's dividend yield?
Suraksha Diagnostic Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹236
Who holds Suraksha Diagnostic Ltd shares — promoters, FII, DII?
Suraksha Diagnostic Ltd's shareholding pattern (Dec 2025)
- Promoters: 49.0%
- FII (Foreign): 13.5%
- DII (Domestic): 22.6%
- Public: 15.0%
Is promoter holding increasing or decreasing in Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd's promoter holding has increased recently.
- Current Promoter Holding: 49.0% (Dec 2025)
- Previous Quarter: 49.0% (Sep 2025)
- Change: +0.02% (increasing — positive signal)
Is Suraksha Diagnostic Ltd a new momentum entry or an established outperformer?
Suraksha Diagnostic Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Suraksha Diagnostic Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Suraksha Diagnostic Ltd may be worth studying
- Cash flow is positive — CFO ₹63 Cr
What is the investment thesis for Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd investment thesis summary:
What is the future outlook for Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.